Science Explorer Back to mapMap
Discussion
Hospital / health system · Reno · United States

Sierra Eye Associates

sierraeyeassociates.comROR OpenAlex
Research works
41
▼ 28% vs 2018-21
Citations
1.1k
25.9 per fractional work
Top-10% rate
29.7%
all institutions 10.0%
Open access
56%
world 40%
International
20%
world 18%
Sierra Eye Associates

Not ranked overall: Sierra Eye Associates is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Sierra Eye Associates work in?

In all years, 80% of research at Sierra Eye Associates is in Health Sciences, 15% in Life Sciences. Its largest fields are Medicine (78%), Biochemistry, Genetics and Molecular Biology (10%), Environmental Science (3%). It does 2.8× the world's share of Health Sciences.

Health Sciences: 32 fractional works · 79.5% of its workMedicine: 32 fractional works · 78.3% of its workOphthalmology: 15 fractional works · 35.7% of its workRadiology, Nuclear Medicine and Imaging: 8 fractional works · 18.7% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 5.4% of its workEpidemiology: 2 fractional works · 4.4% of its workEmergency Medicine: 1 fractional works · 3.5% of its workNeurology: 1 fractional works · 2.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.3% of its workPathology and Forensic Medicine: 1 fractional works · 1.3% of its workSurgery: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.8% of its workPsychiatry and Mental health: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 1.2% of its workGeneral Health Professions: 0 fractional works · 0.6% of its workHealth Information Management: 0 fractional works · 0.3% of its workComplementary and Manual Therapy: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 6 fractional works · 14.6% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 10.1% of its workMolecular Biology: 3 fractional works · 7.1% of its workGenetics: 1 fractional works · 2.1% of its workPhysiology: 0 fractional works · 0.8% of its workImmunology and Microbiology: 1 fractional works · 2.2% of its workImmunology: 1 fractional works · 2.2% of its workNeuroscience: 1 fractional works · 1.6% of its workNeurology: 0 fractional works · 1.0% of its workSensory Systems: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.8% of its workAquatic Science: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.0% of its workPhysical Sciences: 2 fractional works · 5.1% of its workEnvironmental Science: 1 fractional works · 3.3% of its workNature and Landscape Conservation: 1 fractional works · 1.6% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.8% of its workWater Science and Technology: 0 fractional works · 0.8% of its workEngineering: 1 fractional works · 1.6% of its workOcean Engineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.3% of its workMechanics of Materials: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 0 fractional works · 0.2% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.0% of its workSocial Sciences: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 0.5% of its workHealth: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workFinance: 0 fractional works · 0.3% of its workALL ITS WORKSierra EyeAssociates41fractional works, all years
Life Sciences15%Physical Sciences5%Health Sciences80%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine3278.3%
    2. Health Professions01.2%
    1. Biochemistry, Genetics and Molecular Biology410.1%
    2. Immunology and Microbiology12.2%
    3. Neuroscience11.6%
    4. Agricultural and Biological Sciences00.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.0%
    1. Environmental Science13.3%
    2. Engineering11.6%
    3. Chemistry00.2%
    4. Mathematics00.0%
    1. Social Sciences00.5%
    2. Economics, Econometrics and Finance00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.21× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 7.06× its world share, 1 worksImmunology and Micro…Neuroscience: 1.38× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.14× its world share, 0 worksPharmacology, Toxico…Mathematics: 0.04× its world share, 0 worksMathematicsHealth Professions: 0.17× its world share, 0 worksHealth ProfessionsMedicine: 3.80× its world share, 8 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.1×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology7.06×1 works
  2. Medicine3.80×8 works
  3. Biochemistry, Genetics and Molecular Biology3.21×2 works
  4. Neuroscience1.38×0 works
  5. Health Professions0.17×0 works
  6. Pharmacology, Toxicology and Pharmaceutics0.14×0 works
  7. Mathematics0.04×0 works

Who are the top researchers at Sierra Eye Associates?

Ranked on the quality score, Arshad M. Khanani, Carl J. Danzig and Aamir A Aziz lead among researchers whose main affiliation is Sierra Eye Associates.

  1. 1 Arshad M. Khanani United States · #65,819 worldwide 5.4k citations · 157 works
  2. 2 Carl J. Danzig United States · #189,450 worldwide 1.3k citations · 35 works
  3. 3 Aamir A Aziz United States · #1,154,905 worldwide 1.1k citations · 57 works
  4. 4 Lauren Hill United States · #2,664,377 worldwide 478 citations · 47 works
  5. 5 Greggory M Gahn United States · #2,839,093 worldwide 169 citations · 22 works
All ranked researchers at Sierra Eye Associates

What are the most cited papers from Sierra Eye Associates?

The most cited paper from Sierra Eye Associates is "Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials" (Jeffrey S Heier et al., 2022), with 742 citations. Next come "Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial" (364) and "Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema" (290).

Most cited papers
#PaperReleasedCitations
1 Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials Jeffrey S Heier et al. · The Lancet Open access318 authors 24 Jan 2022 742
2 Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial Arshad M. Khanani et al. · The Lancet Open access226 authors 8 Sep 2023 364
3 Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema Jayashree Sahni, Sunil S. Patel, Pravin U. Dugel et al. · Ophthalmology Open access 21 Mar 2019 290
4 TENAYA and LUCERNE Arshad M. Khanani et al. · Ophthalmology Open access317 authors 19 Feb 2024 220
5 Prospective screening of 5,615 high school athletes for risk of sudden cardiac death Colin M. Fuller, CANDACE M. McNULTY, Donald A. Spring et al. · Medicine & Science in Sports & Exercise Sep 1997 202
All 59 most cited papers, with filters and sorting

Which keywords describe research at Sierra Eye Associates?

By fractional works in all years, weighted toward what it does more of than the world: Macular Degeneration, Diabetic Retinopathy, Vascular Endothelial Growth Factor, Intravitreal Injection, Inflammation, Oxidative Stress, Choroidal Thickness and Retinal Pigment Epithelium.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Macular Degeneration14▲ 283×3 topics
  2. Diabetic Retinopathy12▲ 362×2 topics
  3. Vascular Endothelial Growth Factor9▲ 211×3 topics
  4. Inflammation8▲ 8.8×5 topics
  5. Intravitreal Injection8▲ 300×2 topics
  6. Oxidative Stress8▲ 11×5 topics
  7. Choroidal Thickness8▲ 379×1 topic
  8. Retinal Pigment Epithelium8▲ 379×1 topic
  9. Glaucoma6▲ 96×3 topics
  10. Optic Nerve5▲ 133×2 topics
  11. Deep Learning4▲ 5.2×1 topic
  12. Retinal Disease4▲ 302×1 topic
  13. Optical Coherence Tomography4▲ 82×2 topics
  14. Epidemiology4▲ 2.2×8 topics
  15. Myopia3▲ 127×2 topics
  16. COVID-193▲ 11×2 topics
  17. Ocular Findings3▲ 277×1 topic
  18. Retinal Artery Occlusion3▲ 277×1 topic
  19. Gene Therapy2▲ 21×2 topics
  20. OCT Imaging2▲ 156×2 topics
  21. Retinal Stem Cells2▲ 123×1 topic
  22. Retinitis Pigmentosa2▲ 123×1 topic
  23. Macular Hole2▲ 197×1 topic
  24. Vitreoretinal Surgery2▲ 197×1 topic
  25. Juvenile Idiopathic Arthritis2▲ 73×2 topics
  26. Behçet's Disease1▲ 126×1 topic
  27. Clinical Outcomes1▲ 17×3 topics
  28. Genetic Mutations1▲ 6.5×5 topics
  29. Global Prevalence1▲ 37×2 topics
  30. Risk Factors1▲ 3.3×4 topics
  31. Uveitis1▲ 126×1 topic
  32. Refractive Error1▲ 82×1 topic
  33. Visual Impairment1▲ 67×1 topic
  34. Arrhythmias1▲ 22×2 topics
  35. Neurodegeneration1▲ 8.2×3 topics
  36. Emergency Department Crowding1▲ 81×1 topic
  37. Patient Satisfaction1▲ 9.8×1 topic
  38. Sudden Death1▲ 51×2 topics

Which research topics does Sierra Eye Associates publish most on?

By volume in 2022-now: Retinal Diseases and Treatments, Retinal Development and Disorders, Ophthalmology and Visual Impairment Studies and Retinal Imaging and Analysis.

Retinal Diseases and Tre…3Retinal Diseases and Treatments: 3 fractional worksRetinal Development and …1Retinal Development and Disorders: 1 fractional worksOphthalmology and Visual…1Ophthalmology and Visual Impairment Studies: 1 fractional worksRetinal Imaging and Analysis: 1 fractional worksComplement system in diseases: 1 fractional worksOcular Diseases and Behç…1Ocular Diseases and Behçet’s Syndrome: 1 fractional worksRetinal and Optic Conditions: 1 fractional worksRetinal and Macular Surgery: 0 fractional worksRetinopathy of Prematurity Studies: 0 fractional worksGlaucoma and retinal disorders: 0 fractional works
OphthalmologyMolecular BiologyEpidemiologyRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Retinal Diseases and Treatments Ophthalmology 3 works
  2. 2 Retinal Development and Disorders Molecular Biology 1 works
  3. 3 Ophthalmology and Visual Impairment Studies Epidemiology 1 works
  4. 4 Retinal Imaging and Analysis Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Complement system in diseases Immunology 1 works
  6. 6 Ocular Diseases and Behçet’s Syndrome Ophthalmology 1 works
  7. 7 Retinal and Optic Conditions Ophthalmology 1 works
  8. 8 Retinal and Macular Surgery Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Retinopathy of Prematurity Studies Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Glaucoma and retinal disorders Ophthalmology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.1%not open43.9%

World: 40% of research is openly available.

with international co-authors20.5%domestic only79.5%

World: 18% is written across borders.

How has Sierra Eye Associates's research output changed?

Output in 2022-2025 was 28% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sierra Eye Associates as a percentage of every work published that year, 0.000063% in 2024.

still counting0.00020%0.00040%Sierra Eye Associates0.000036% in 202519801990200020102020

Fractional works of Sierra Eye Associates over all fractional works that year. How the balance of science has shifted.

Other research institutions in Reno

All research institutions in Reno

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sierra Eye Associates. Posts are plain text and can be reported.